The Hunter Translational Cancer Research Unit (HTCRU) was established in 2011 to develop and translate new cancer research discoveries into improved cancer outcomes. The HTCRU is funded by the Cancer Institute NSW under the Translational Research Program.
The Hunter Translational Cancer Research Unit (HTCRU) is a functional aggregation of collaborating facilities in basic, clinical and population based research. Within the Unit there is substantial cross-disciplinary collaboration, with links to large scale cancer treatment programs (including clinical care and professional education and training).
The HTCRU Integrated Approach
The HTCRU brings together more than 120 of our region’s top researchers from the University of Newcastle, Hunter Medical Research Institute, Calvary Mater Newcastle, Hunter New England Local Health District, and Hunter Area Pathology Service to enhance connections between research and clinical care. It integrates the elements of the bi-directional research pathway from basic science to clinical care and ultimately patients.